412 related articles for article (PubMed ID: 29066891)
1. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles.
Mady FM; Shaker MA
Int J Nanomedicine; 2017; 12():7405-7417. PubMed ID: 29066891
[TBL] [Abstract][Full Text] [Related]
2. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats.
Sonaje K; Italia JL; Sharma G; Bhardwaj V; Tikoo K; Kumar MN
Pharm Res; 2007 May; 24(5):899-908. PubMed ID: 17377747
[TBL] [Abstract][Full Text] [Related]
3. Poly(ε-benzyloxycarbonyl-L-lysine)-grafted branched polyethylenimine as efficient nanocarriers for indomethacin with enhanced oral bioavailability and anti-inflammatory efficacy.
Lu C; Li X; Xia W; Lu S; Luo H; Ye D; Zhang Y; Liu D
Acta Biomater; 2017 Feb; 49():434-443. PubMed ID: 27867110
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles.
Feng R; Song Z; Zhai G
Int J Nanomedicine; 2012; 7():4089-98. PubMed ID: 22888245
[TBL] [Abstract][Full Text] [Related]
5. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
6. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB).
Arulmozhi V; Pandian K; Mirunalini S
Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810
[TBL] [Abstract][Full Text] [Related]
7. Oral delivery of capsaicin using MPEG-PCL nanoparticles.
Peng W; Jiang XY; Zhu Y; Omari-Siaw E; Deng WW; Yu JN; Xu XM; Zhang WM
Acta Pharmacol Sin; 2015 Jan; 36(1):139-48. PubMed ID: 25434988
[TBL] [Abstract][Full Text] [Related]
8. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K
Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115
[TBL] [Abstract][Full Text] [Related]
9. Cyclodextrin-based nanosponge for improvement of solubility and oral bioavailability of Ellagic acid.
Mady FM; Ibrahim SR
Pak J Pharm Sci; 2018 Sep; 31(5(Supplementary)):2069-2076. PubMed ID: 30393214
[TBL] [Abstract][Full Text] [Related]
10. Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation.
El-Habashy SE; Allam AN; El-Kamel AH
Int J Nanomedicine; 2016; 11():2369-80. PubMed ID: 27307735
[TBL] [Abstract][Full Text] [Related]
11. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
[TBL] [Abstract][Full Text] [Related]
12. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
13. Oral delivery of indinavir using mPEG-PCL nanoparticles: preparation, optimization, cellular uptake, transport and pharmacokinetic evaluation.
Kurd M; Sadegh Malvajerd S; Rezaee S; Hamidi M; Derakhshandeh K
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2123-2133. PubMed ID: 31155961
[No Abstract] [Full Text] [Related]
14. Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly(epsilon-caprolactone) nanoparticles by a spray-drying method.
Tshweu L; Katata L; Kalombo L; Chiappetta DA; Hocht C; Sosnik A; Swai H
Nanomedicine (Lond); 2014; 9(12):1821-33. PubMed ID: 24364871
[TBL] [Abstract][Full Text] [Related]
15. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole.
Ahmed TA; Aljaeid BM
Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of atorvastatin oral bioavailability via encapsulation in polymeric nanoparticles.
Shaker MA; Elbadawy HM; Al Thagfan SS; Shaker MA
Int J Pharm; 2021 Jan; 592():120077. PubMed ID: 33246047
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of letrozole-loaded poly(d,l-lactide) nanoparticles for drug delivery in breast cancer therapy.
Alemrayat B; Elhissi A; Younes HM
Pharm Dev Technol; 2019 Feb; 24(2):235-242. PubMed ID: 29561210
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
[TBL] [Abstract][Full Text] [Related]
19. Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles.
Ashour AE; Badran M; Kumar A; Hussain T; Alsarra IA; Yassin AEB
Int J Nanomedicine; 2019; 14():9259-9273. PubMed ID: 31819428
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations.
Tariq M; Alam MA; Singh AT; Iqbal Z; Panda AK; Talegaonkar S
Colloids Surf B Biointerfaces; 2015 Apr; 128():448-456. PubMed ID: 25769281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]